Bancel Stephane

Director · Officer · MRNA, GENB

As of 2026-09-16, Bancel Stephane has 24 Form 4 transactions on record across 2 companies — 19 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $464KIndirect: $1.4B$1.4Bas of 2026-09-16
  • Direct $464K
  • Indirect $1.4B
MRNAindirect9,210,686 sh$1.3B
GENBindirect724,160 sh$11.4M
GENBdirect29,561 sh$464K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

MRNA · 20 trades
2026-08-06: Option exercise, 252,469 sh ($4.8M)2026-08-06: Option exercise, 64,928 sh ($0)2026-08-06: Option exercise, 187,541 sh ($0)2026-08-05: Sale, 187,044 sh ($11.0M)2026-08-05: Option exercise, 499,246 sh ($9.6M)2026-08-05: Sale, 147,473 sh ($8.3M)2026-08-05: Sale, 124,838 sh ($7.1M)2026-08-05: Sale, 39,891 sh ($2.3M)2026-08-05: Option exercise, 370,853 sh ($0)2026-08-05: Option exercise, 128,393 sh ($0)2026-03-01: Award / grant, 250,932 sh ($0)2026-02-11: Withheld for tax, 5,450 sh ($229K)2026-02-11: Award / grant, 11,271 sh ($0)2025-12-11: Option exercise, 688,073 sh ($7.5M)2025-12-11: Option exercise, 688,073 sh ($0)2025-03-03: Purchase, 102,821 sh ($3.2M)2025-03-03: Purchase, 57,493 sh ($1.8M)2025-03-01: Award / grant, 357,065 sh ($0)2025-02-12: Withheld for tax, 6,400 sh ($198K)2025-02-12: Award / grant, 13,233 sh ($0)
GENB · 4 trades
2026-03-02: Conversion, 1,100,000 sh ($0)2026-03-02: Conversion, 724,160 sh2026-03-02: Conversion, 724,160 sh2026-02-26: Award / grant, 29,561 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-08-05MRNASale187,044 @ $58.79$11.0M−2.9% of holding6,187,791Form 4
2026-08-05MRNASale147,473 @ $56.21$8.3M−2.2% of holding6,539,564Form 4
2026-08-05MRNASale124,838 @ $56.96$7.1M−1.9% of holding6,414,726Form 4
2026-08-05MRNASale39,891 @ $58.12$2.3M−0.6% of holding6,374,835Form 4
2025-03-03MRNAPurchase102,821 @ $31.04$3.2M+1.1% of holding9,153,193Form 4
2025-03-03MRNAPurchase57,493 @ $31.53$1.8M+0.6% of holding9,210,686Form 4
18 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-08-06MRNAOption exercise252,4696,440,260Form 4
2026-08-06MRNAOption exercise64,9280Form 4
2026-08-06MRNAOption exercise187,5410Form 4
2026-08-05MRNAOption exercise499,2466,687,037Form 4
2026-08-05MRNAOption exercise370,853187,541Form 4
2026-08-05MRNAOption exercise128,39364,928Form 4
2026-03-02GENBConversion1,100,0000Form 4
2026-03-02GENBConversion724,160724,160Form 4
2026-03-02GENBConversion724,160724,160Form 4
2026-03-01MRNAAward / grant250,932250,932Form 4
2026-02-26GENBAward / grant29,56129,561Form 4
2026-02-11MRNAWithheld for tax5,4506,187,791Form 4
2026-02-11MRNAAward / grant11,2716,193,241Form 4
2025-12-11MRNAOption exercise688,0736,181,970Form 4
2025-12-11MRNAOption exercise688,0730Form 4
2025-03-01MRNAAward / grant357,065357,065Form 4
2025-02-12MRNAWithheld for tax6,4005,493,897Form 4
2025-02-12MRNAAward / grant13,2335,500,297Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.